Meteor Pharma Private Limited
About Meteor Pharma Private Limited
Data last updated:
Meteor Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 January 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2010PTC199160. Its GSTIN is 10AAGCM6345P1Z8 (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.25 Lakh. It is led by directors Gauri Shankar Sahay and Sovna Sinha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 102 Neeraj Park – 2 R.N.P.Park Bandh Road Bhayandar East, Thane, Maharashtra, India – 400105.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.61 Lakh, a growth of 84% compared to the previous year. For the same year it recorded a net profit of ₹83,411 (net margin 3.4%) and EBITDA of ₹1.21 Lakh (EBITDA margin 4.9%).
As per MCA filings, the company has open charges of ₹5.5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressA – 102 Neeraj Park – 2 R.N.P.Park Bandh Road Bhayandar East, Thane, Maharashtra, India – 400105
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Meteor Pharma Private Limited
The main business activity of Meteor Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Meteor Pharma Private Limited FY 2025 filings available
Meteor Pharma Private Limited reported revenue of ₹24.61 Lakh (up 84% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Meteor Pharma Private Limited
Revenue rose 84% in the latest year. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Meteor Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.21 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹83,411 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Meteor Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Meteor Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Meteor Pharma Private Limited
Meteor Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gauri Shankar Sahay | Director | 20 Mar 2025 | 1 Years 7 Months | Current |
| Sovna Sinha | Director | 22 Sep 2014 | 12 Years 0 Months | Current |
Peer Comparison of Meteor Pharma Private Limited
Meteor Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Innovexa Healthcare Private Limited | ₹24.78 Lakh (FY 2024) | •••• | •••• | 35.0% | •••• | Jabalpur, Madhya Pradesh, India |
| Astima Pharmaceuticals Private Limited | ₹24.77 Lakh (FY 2024) | •••• | •••• | 24.0% | •••• | Gurugram, Haryana, India |
| Dr Chantis Pharmaceuticals Private Limited | ₹24.75 Lakh (FY 2022) | •••• | •••• | 7.0% | •••• | Ongole, Andhra Pradesh, India |
| Biostone Pharmaceuticals Private Limited | ₹24.71 Lakh (FY 2025) | •••• | •••• | 16.0% | •••• | Delhi, India |
| Benz Lifecare Private Limited | ₹24.68 Lakh (FY 2024) | •••• | •••• | -19.0% | •••• | Delhi, India |
| Meteor Pharma Private Limited this company | ₹24.61 Lakh (FY 2025) | •••• | •••• | 84.0% | •••• | Thane, Maharashtra, India |
| Reitrue Pharmaceutical Private Limited | ₹24.61 Lakh (FY 2019) | •••• | •••• | 347.0% | •••• | Thane, Maharashtra, India |
| Global Herbals India Private Limited | ₹24.55 Lakh (FY 2016) | •••• | •••• | 391.0% | •••• | Gurgaon, Haryana, India |
| Tribune Healthcare Private Limited | ₹24.53 Lakh (FY 2024) | •••• | •••• | -5.0% | •••• | New Delhi, Delhi, India |
| Kanta Biotech Private Limited | ₹24.49 Lakh (FY 2025) | •••• | •••• | 269.0% | •••• | Tiswadi, Goa, India |
| Vacslife Pharmaceuticals Private Limited | ₹24.44 Lakh (FY 2021) | •••• | •••• | -56.0% | •••• | Shillong, Meghalaya, India |
Peers are the five companies nearest above and the five nearest below Meteor Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Meteor Pharma Private Limited
Meteor Pharma Private Limited is audited by C. S. P. & ASSOCIATES LLP for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| C. S. P. & ASSOCIATES LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Meteor Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Meteor Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jul 2011 | State Bank of India | ₹5.5 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Meteor Pharma Private Limited
Employment history and EPFO contributions of people linked to Meteor Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Meteor Pharma Private Limited
Meteor Pharma Private Limited has 6 board changes on record since 2014: 3 appointments and 3 cessations. The latest: Gokula Nand Sahay ceased to be Additional Director on 21 Mar 2025.
Credit Ratings, Litigation & Regulatory Alerts for Meteor Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Meteor Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Meteor Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Meteor Pharma Private Limited
Meteor Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAGCM6345P1Z8 | Bihar | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Meteor Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Meteor Pharma Private Limited
Meteor Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 January 2010 (16+ years old) and is registered under CIN U24239MH2010PTC199160.
Meteor Pharma reported revenue of ₹24.61 Lakh for FY 2025 (up 84% YoY).
Meteor Pharma has 2 current directors:
- Gauri Shankar Sahay - Director
- Sovna Sinha - Director
Meteor Pharma reported a net profit of ₹83,411 (net margin 3.4%) and EBITDA of ₹1.21 Lakh (EBITDA margin 4.9%) for FY 2025, as per its filed financial statements.
The GSTIN of Meteor Pharma is 10AAGCM6345P1Z8, registered in Bihar.
The CIN (Corporate Identification Number) of Meteor Pharma is U24239MH2010PTC199160. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meteor Pharma was incorporated on 21 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Meteor Pharma by revenue are Innovexa Healthcare Private Limited, Astima Pharmaceuticals Private Limited, Dr Chantis Pharmaceuticals Private Limited, Biostone Pharmaceuticals Private Limited, Benz Lifecare Private Limited and 5 more, all in the Pharma industry (Formulations).
Gokula Nand Sahay ceased to be Additional Director on 21 Mar 2025. Gauri Shankar Sahay was appointed as Director on 20 Mar 2025. Gauri Shankar Sahay ceased to be Director on 30 Sep 2016. Meteor Pharma has 6 board changes on record in total.
The registered office of Meteor Pharma is at A – 102 Neeraj Park – 2 R.N.P.Park Bandh Road Bhayandar East, Thane, Maharashtra, India – 400105.
Meteor Pharma has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.25 Lakh.